Amedeo Smart

Free Medical Literature Service

 

Amedeo

Bacterial Infections and Mycoses
  Free Subscription

Articles published in
Am J Respir Crit Care Med
    April 2024
  1. GAUSI K, Ignatius EH, De Jager V, Upton C, et al
    High-Dose Isoniazid Lacks EARLY Bactericidal Activity Against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized, Phase 2 Clinical Trial.
    Am J Respir Crit Care Med. 2024 Apr 2. doi: 10.1164/rccm.202311-2004.
    >> Share

  2. ZHANG M, Luo Q, Li X, Mu X, et al
    Pulmonary Artery Pseudoaneurysm Caused by Pulmonary Mucormycosis.
    Am J Respir Crit Care Med. 2024;209:879-880.
    >> Share

    March 2024
  3. AHMAD S, Wrennall JA, Goriounova AS, Sekhri M, et al
    Specific Inhibition of Orai1-mediated Calcium Signalling Resolves Inflammation and Clears Bacteria in an Acute Respiratory Distress Syndrome Model.
    Am J Respir Crit Care Med. 2024;209:703-715.
    >> Share

    February 2024
  4. TREVISI L, Brooks MB, Becerra MC, Calderon RI, et al
    Who Transmits Tuberculosis to Whom: A Cross-Sectional Analysis of a Cohort Study in Lima, Peru.
    Am J Respir Crit Care Med. 2024 Feb 28. doi: 10.1164/rccm.202307-1217.
    >> Share

  5. LIN CF, Wu YW, Liao WA, Lin CY, et al
    Right Atrial Angiosarcoma with Embolic Lung Metastases Masquerading as Atypical Pneumonitis.
    Am J Respir Crit Care Med. 2024;209:325-328.
    >> Share

  6. XIA L, Hantrakun V, Teparrukkul P, Wongsuvan G, et al
    Plasma Metabolomics Reveals Distinct Biological and Diagnostic Signatures for Melioidosis.
    Am J Respir Crit Care Med. 2024;209:288-298.
    >> Share

    January 2024
  7. LAGHLAM D, Giraud F, Benghanem S
    Severe Pulmonary and Nasopharyngeal Candida Krusei Infection in Cocaine-induced Vasculopathy.
    Am J Respir Crit Care Med. 2024 Jan 11. doi: 10.1164/rccm.202305-0828.
    >> Share

    December 2023
  8. TSIN WEN Y, Cheng AC, Podin Y
    Precision Medicine for Sepsis Management in Low- and Middle-Income Countries - Melioidosis as a Model?
    Am J Respir Crit Care Med. 2023 Dec 6. doi: 10.1164/rccm.202311-2056.
    >> Share

  9. NATHANI A, Tauquir A, Khan S, Arrossi AV, et al
    Unusual Presentation of Pneumocystis jirovecii Pneumonia in an Immunocompromised Host.
    Am J Respir Crit Care Med. 2023;208:e44-e46.
    >> Share

    November 2023
  10. FEYS S, Hoenigl M, Gangneux JP MD, PhD, FECMM, Verweij PE, et al
    Fungal Fog in Viral Storms: Necessity for Rigor in Aspergillosis Diagnosis and Research.
    Am J Respir Crit Care Med. 2023 Nov 16. doi: 10.1164/rccm.202310-1815.
    >> Share

  11. LONG DR, Holmes EA, Goss CH, Singh PK, et al
    Cell-Free DNA Detects Pseudomonas aeruginosa Lung Infection in Modulator-treated People with Cystic Fibrosis.
    Am J Respir Crit Care Med. 2023;208:944-947.
    >> Share

    October 2023
  12. ANIDI IU, Kirenga B, Fennelly KP
    Pulmonary Rehabilitation for Post-Tuberculosis Lung Disease.
    Am J Respir Crit Care Med. 2023 Oct 5. doi: 10.1164/rccm.202309-1571.
    >> Share

  13. ROCHESTER CL, Alison JA, Carlin B, Holland AE, et al
    Reply to: Pulmonary Rehabilitation for Post-Tuberculosis Lung Disease.
    Am J Respir Crit Care Med. 2023 Oct 5. doi: 10.1164/rccm.202309-1714.
    >> Share

  14. SAEKI Y, Moriyama Y, Araki Y, Oda A, et al
    Gas Gangrene after Thoracic Drainage for Empyema with Tension Pneumothorax.
    Am J Respir Crit Care Med. 2023;208:814-815.
    >> Share

    August 2023
  15. HILL H, Mitsi E, Nikolaou E, Blizard A, et al
    A Randomised Controlled Trial of Nasal Immunisation with Live Virulence Attenuated Streptococcus pneumoniae Strains Using Human Infection Challenge.
    Am J Respir Crit Care Med. 2023 Aug 9. doi: 10.1164/rccm.202302-0222.
    >> Share

    July 2023
  16. OTTEWILL C, Dolan L, Lopez Bailen E, Roycroft E, et al
    Immunosuppressed Pets as a Conduit for Zoonotic Tuberculosis.
    Am J Respir Crit Care Med. 2023 Jul 25. doi: 10.1164/rccm.202304-0734.
    >> Share

    June 2023
  17. ALBRICH WC, Lamoth F
    Viral-associated Pulmonary Aspergillosis: Have We Finally Overcome the Debate of Colonization Versus Infection?
    Am J Respir Crit Care Med. 2023 Jun 22. doi: 10.1164/rccm.202306-1022.
    >> Share

  18. VANDERBEKE L, Jacobs C, Feys S, Resendiz-Sharpe A, et al
    A Pathology-based Case Series of Influenza- and COVID-19-associated Pulmonary Aspergillosis: The Proof Is in the Tissue.
    Am J Respir Crit Care Med. 2023 Jun 13. doi: 10.1164/rccm.202208-1570.
    >> Share

  19. PATANKAR S, Cruz AT, Douglas-Jones B, Garcia-Prats A, et al
    Making the Case for All-Oral, Shorter Regimens for Children with Drug-Resistant Tuberculosis.
    Am J Respir Crit Care Med. 2023 Jun 5. doi: 10.1164/rccm.202304-0670.
    >> Share

  20. BRUST JCM
    "Weighting" the Evidence: How Much Bedaquiline Is Enough?
    Am J Respir Crit Care Med. 2023;207:1423-1424.
    >> Share

    May 2023
  21. MITNICK CD, Nunn AJ
    Ascertainment Bias in TB Treatment Trials: Can Systematic Assessment of Objective Endpoints Solve It?
    Am J Respir Crit Care Med. 2023;207:1269-1270.
    >> Share

  22. KURBATOVA EV, Phillips PPJ, Dorman SE, Sizemore EE, et al
    A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase Tuberculosis Clinical Trials.
    Am J Respir Crit Care Med. 2023;207:1376-1382.
    >> Share

  23. LIU Y, Xu J, Wang C, Lu B, et al
    Pulmonary Mucormycosis with Rib Involvement in an Immunocompromised Patient.
    Am J Respir Crit Care Med. 2023;207:1393-1394.
    >> Share

    April 2023
  24. BORGES DE ALMEIDA CP, Mitnick CD
    Intervening on Social Determinants for Better Outcomes in Pediatric Tuberculosis Management.
    Am J Respir Crit Care Med. 2023 Apr 19. doi: 10.1164/rccm.202303-0601.
    >> Share

  25. MARTINEZ L, Zar HJ
    Reply to: Intervening on Social Determinants for Better Outcomes in Pediatric Tuberculosis Management.
    Am J Respir Crit Care Med. 2023 Apr 19. doi: 10.1164/rccm.202304-0629.
    >> Share

  26. MASEKELA R, Mandalakas AM
    Pediatric Post-TB Lung Disease: Ready for Prime Time?
    Am J Respir Crit Care Med. 2023;207:975-977.
    >> Share

    February 2023
  27. TREVISI L, Hernan MA, Mitnick CD, Khan U, et al
    Effectiveness of Bedaquiline Use Beyond Six Months in Patients with Multidrug-Resistant Tuberculosis.
    Am J Respir Crit Care Med. 2023 Feb 21. doi: 10.1164/rccm.202211-2125.
    >> Share

  28. MARTINEZ L, Gray DM, Botha M, Nel M, et al
    The Long-Term Impact of Early-Life Tuberculosis Disease on Child Health: A Prospective Birth Cohort Study.
    Am J Respir Crit Care Med. 2023 Feb 6. doi: 10.1164/rccm.202208-1543.
    >> Share

    January 2023
  29. STAGG HR, Thompson JA, Lipman MCI, Sloan DJ, et al
    Forgiveness Is the Attribute of the Strong: Nonadherence and Regimen Shortening in Drug-sensitive Tuberculosis.
    Am J Respir Crit Care Med. 2023;207:193-205.
    >> Share

  30. VELASQUEZ GE, Nahid P
    Promise and Peril of Pretomanid-Rifamycin Regimens for Drug-Susceptible Tuberculosis.
    Am J Respir Crit Care Med. 2023 Jan 11. doi: 10.1164/rccm.202212-2262.
    >> Share

    December 2022
  31. DOOLEY KE, Hendricks B, Gupte N, Barnes G, et al
    Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results.
    Am J Respir Crit Care Med. 2022 Dec 1. doi: 10.1164/rccm.202208-1475.
    >> Share


  32. Erratum: Response to Hypoxia and the Ensuing Dysregulation of Inflammation Impacts Mycobacterium tuberculosis Pathogenicity.
    Am J Respir Crit Care Med. 2022;206:1434.
    >> Share

  33. HENRIQUES-NORMARK B, Narciso AR
    An Experimental Human Colonization Model with Pneumococcal Serotype 3 has the Potential to be Used for Vaccine Studies.
    Am J Respir Crit Care Med. 2022;206:1312-1314.
    >> Share

  34. ROBINSON RE, Mitsi E, Nikolaou E, Pojar S, et al
    Human Infection Challenge with Serotype 3 Pneumococcus.
    Am J Respir Crit Care Med. 2022;206:1379-1392.
    >> Share

    November 2022
  35. BEENTJES D, Shears RK, French N, Neill DR, et al
    Mechanistic Insights into the Impact of Air Pollution on Pneumococcal Pathogenesis and Transmission.
    Am J Respir Crit Care Med. 2022;206:1070-1080.
    >> Share

    October 2022
  36. CHECKLEY W
    Tuberculosis, Wildfires, and Case-Crossover Studies: An Epidemiological Trifecta?
    Am J Respir Crit Care Med. 2022 Oct 31. doi: 10.1164/rccm.202210-1936.
    >> Share

    September 2022

  37. Erratum: Optimizing the Design of Latent Tuberculosis Treatment Trials: Insights from Mathematical Modeling.
    Am J Respir Crit Care Med. 2022;206:800-801.
    >> Share

  38. LINDE LR, Readhead A, Barry PM, Balmes JR, et al
    Tuberculosis Diagnoses Following Wildfire Smoke Exposure in California.
    Am J Respir Crit Care Med. 2022 Sep 14. doi: 10.1164/rccm.202203-0457.
    >> Share

    June 2022
  39. MARAIS BJ, Graham SM
    The Value of Chest Radiography in Tuberculosis Preventive Treatment (TPT) Screening in Children and Adolescents.
    Am J Respir Crit Care Med. 2022 Jun 2. doi: 10.1164/rccm.202205-1023.
    >> Share

    May 2022
  40. DOWDY DW
    Coughing is Not Required to Transmit Mycobacterium tuberculosis: Another Nail in the Coffin.
    Am J Respir Crit Care Med. 2022 May 25. doi: 10.1164/rccm.202204-0645.
    >> Share

  41. HUANG CC, Tan Q, Becerra MC, Calderon R, et al
    The Contribution of Chest Radiography to the Clinical Management of Children Exposed to Tuberculosis.
    Am J Respir Crit Care Med. 2022 May 24. doi: 10.1164/rccm.202202-0259.
    >> Share

  42. DINKELE R, Gessner S, McKerry A, Leonard B, et al
    Aerosolization of Mycobacterium tuberculosis by Tidal Breathing.
    Am J Respir Crit Care Med. 2022 May 18. doi: 10.1164/rccm.202110-2378.
    >> Share

  43. TOBIN MJ
    Fiftieth Anniversary of Uncovering the Tuskegee Syphilis Study: The Story and Timeless Lessons.
    Am J Respir Crit Care Med. 2022;205:1145-1158.
    >> Share

  44. DE JAGER V, Gupte N, Nunes S, Barnes GL, et al
    Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical Trial.
    Am J Respir Crit Care Med. 2022;205:1228-1235.
    >> Share

  45. ESMAIL A, Oelofse S, Lombard C, Perumal R, et al
    An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study).
    Am J Respir Crit Care Med. 2022;205:1214-1227.
    >> Share

  46. OLIVIER KN, Prevots DR
    HALTing Nontuberculous Mycobacteria in Cystic Fibrosis Centers: Is There Something in the Water?
    Am J Respir Crit Care Med. 2022;205:982-983.
    >> Share

  47. GROSS JE, Caceres S, Poch K, Hasan NA, et al
    Investigating Nontuberculous Mycobacteria Transmission at the Colorado Adult Cystic Fibrosis Program.
    Am J Respir Crit Care Med. 2022;205:1064-1074.
    >> Share

    April 2022
  48. SHAKU MT, Bishai WR
    Mycobacterium tuberculosis: A Pathogen That Can Hold its Breath a Long Time.
    Am J Respir Crit Care Med. 2022 Apr 20. doi: 10.1164/rccm.202203-0432.
    >> Share

  49. BUCSAN AN, Veatch A, Singh DK, Akter S, et al
    Response to Hypoxia and the Ensuing Dysregulation of Inflammation Impacts Mycobacterium tuberculosis Pathogenicity.
    Am J Respir Crit Care Med. 2022 Apr 12. doi: 10.1164/rccm.202112-2747.
    >> Share

  50. PITTET LF, Fritschi N, Tebruegge M, Dutta B, et al
    Bacillus Calmette-Guerin Skin Reaction Predicts Enhanced Mycobacteria-Specific T-Cell Responses in Infants: A Post Hoc Analysis of a Randomized Controlled Trial.
    Am J Respir Crit Care Med. 2022;205:830-841.
    >> Share

    March 2022
  51. LANGE C, Barry Iii CE, Horsburgh CR Jr
    Treatments of Multidrug-Resistant Tuberculosis: Light at the End of the Tunnel.
    Am J Respir Crit Care Med. 2022 Mar 23. doi: 10.1164/rccm.202202-0393.
    >> Share

    February 2022
  52. COOKSON W, Moffatt M, Rapeport G, Quint J, et al
    A Pandemic Lesson for Global Lung Diseases: Exacerbations are Preventable.
    Am J Respir Crit Care Med. 2022 Feb 22. doi: 10.1164/rccm.202110-2389.
    >> Share

    January 2022
  53. SCHLUGER NW
    Of Mice and Men, Women, and Children: Using Animal Models to Inform Tuberculosis Clinical Trials of Novel Agents.
    Am J Respir Crit Care Med. 2022 Jan 31. doi: 10.1164/rccm.202112-2866.
    >> Share

  54. CHO HJ, Yu JH
    Quincke's Sign of Janeway Lesion in Infective Endocarditis.
    Am J Respir Crit Care Med. 2022 Jan 27. doi: 10.1164/rccm.202110-2362.
    >> Share

  55. O'DONNELL M, Mathema B
    Expanding the Tuberculosis Cascade of Care to Treat Undiagnosed and Subclinical Tuberculosis in High-Burden Settings.
    Am J Respir Crit Care Med. 2022;205:149-151.
    >> Share

    December 2021
  56. KAUSHIK A, Ammerman NC, Tasneen R, Lachau-Durand S, et al
    Efficacy of Long-Acting Bedaquiline Regimens in a Mouse Model of Tuberculosis Preventive Therapy.
    Am J Respir Crit Care Med. 2021 Dec 23. doi: 10.1164/rccm.202012-4541.
    >> Share

  57. FENNELLY KP, Martinez L, Mandalakas AM
    Tuberculosis: First in Flight.
    Am J Respir Crit Care Med. 2021 Dec 14. doi: 10.1164/rccm.202111-2513.
    >> Share

  58. SHIMIZU T, Watanabe S, Murata A, Kasahara K, et al
    Bronchial Cast Hiding Pulmonary Tuberculosis.
    Am J Respir Crit Care Med. 2021 Dec 3. doi: 10.1164/rccm.202105-1306.
    >> Share

  59. SCHLUGER NW
    Using Isoniazid More Safely and More Effectively: The Time Is Now.
    Am J Respir Crit Care Med. 2021;204:1248-1250.
    >> Share

  60. WATERS V
    Two Steps Forward: Improving the Management of Cystic Fibrosis Pulmonary Exacerbations.
    Am J Respir Crit Care Med. 2021;204:1245-1247.
    >> Share

    November 2021
  61. BUNYASI EW, Middelkoop K, Koch A, Hoosen Z, et al
    Molecular Detection of Airborne Mycobacterium tuberculosis in South African High Schools.
    Am J Respir Crit Care Med. 2021 Nov 9. doi: 10.1164/rccm.202102-0405.
    >> Share

  62. ADJOBIMEY M, Behr MA, Menzies D
    Individualized Treatment Duration in Tuberculosis Treatment: Precision versus Simplicity.
    Am J Respir Crit Care Med. 2021;204:1013-1014.
    >> Share

    October 2021
  63. ATRE SR, Jagtap JD, Faqih MI, Dumbare YK, et al
    Tuberculosis Pathways to Care and Transmission of Multidrug-Resistance in India.
    Am J Respir Crit Care Med. 2021 Oct 27. doi: 10.1164/rccm.202012-4333.
    >> Share

  64. NOURSADEGHI M, Gupta RK
    New Insights into the Limitations of Host-Transcriptional Biomarkers of Tuberculosis.
    Am J Respir Crit Care Med. 2021 Oct 27. doi: 10.1164/rccm.202109-2146.
    >> Share

    September 2021
  65. LU S, Kolls JK
    Early Antibiotics in Cystic Fibrosis: Lessons from the Cystic Fibrosis Pig Model.
    Am J Respir Crit Care Med. 2021;204:626-627.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016